Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Ercp With Suprapapillary Stent Placement

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07325877Not ApplicableNot Yet Recruiting

Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis

NCT06933576Completed

Contribution of the EyeMAX™ 11Fr (Micro-Tech) Digital Single-Operator Cholangioscope With a Wide Working Channel

NCT00487201Not ApplicableCompleted

Endoscopic Treatment of Biliary Strictures After LTX: Balloon Dilatation Versus Stent Placement

Showing all 3 trials

Research Network

Common Treatments

  • Ercp With Suprapapillary Stent Placement1
  • Dsoc Eyemax 11fr1
  • Endoscopic Balloon Dilatation1
  • Ercp With Transpapillary Stent Placement1
  • Plastic Stent Placement1

Active Sponsors

  • Clinique Paris-Bercy1
  • University of Ulm1
  • Azienda Ospedaliera Universitaria Integrata Verona1

Top Investigators

Related Conditions

  • Bile Duct Stones1
  • Biliary Stricture1
  • Biliary Disease Tract1
  • Biliary Obstruction1
  • Biliary Stents1

Activity Timeline